Ribonucleoside Diphosphate Reductase, antagonists & inhibitors

Name
Ribonucleoside Diphosphate Reductase, antagonists & inhibitors
Accession Number
DBCAT001805
Description

Not Available

Drugs
DrugDrug Description
TezacitabineInvestigated for use/treatment in colorectal cancer, lung cancer, leukemia (unspecified), and gastric cancer.
Drugs & Drug Targets
DrugTargetType
TezacitabineRibonucleoside-diphosphate reductase large subunittarget
TezacitabineThymidine phosphorylaseenzyme